We are live on ! Find out more
PAHC icon

Phibro Animal Health

153 hedge funds and large institutions have $409M invested in Phibro Animal Health in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 63 increasing their positions, 46 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 15

37% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 46

6% more funds holding

Funds holding: 145153 (+8)

0.44% more ownership

Funds ownership: 100.51%100.96% (+0.44%)

2% less capital invested

Capital invested by funds: $417M → $409M (-$7.94M)

Holders
153
Holders Change
+8
Holders Change %
+5.52%
% of All Funds
2.41%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
23
Increased
63
Reduced
46
Closed
15
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$75.6M +$4.11M +203,652 +6%
Vanguard Group
2
Vanguard Group
Pennsylvania
$45.5M +$76.7K +3,797 +0.2%
Pzena Investment Management
3
Pzena Investment Management
New York
$31.5M +$3.5M +173,137 +12%
FMI
4
Fiduciary Management Inc
Wisconsin
$23.2M -$8.78M -435,036 -27%
State Street
5
State Street
Massachusetts
$16.7M +$570K +28,224 +3%
HA
6
Heartland Advisors
Wisconsin
$15.5M +$26.4K +1,306 +0.2%
Goldman Sachs
7
Goldman Sachs
New York
$13.7M +$203K +10,065 +1%
Principal Financial Group
8
Principal Financial Group
Iowa
$12.6M +$588K +29,142 +5%
Renaissance Technologies
9
Renaissance Technologies
New York
$12M -$781K -38,700 -6%
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$10.2M +$873K +43,233 +9%
DRZID
11
DePrince Race & Zollo Inc (DRZ)
Florida
$9.56M +$1.85M +91,835 +24%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$8.7M -$141K -6,989 -2%
Victory Capital Management
13
Victory Capital Management
Texas
$7.88M +$2.95M +145,990 +50%
PAIM
14
Punch & Associates Investment Management
Minnesota
$7.83M +$303K +15,006 +4%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$7.22M +$185K +9,161 +3%
N
16
Nuveen
North Carolina
$6.62M -$77.6K -3,844 -1%
SGCIA
17
Smith Graham & Co Investment Advisors
Texas
$6.5M -$43.1K -2,133 -0.7%
Charles Schwab
18
Charles Schwab
California
$5.14M +$1.25M +62,074 +32%
Northern Trust
19
Northern Trust
Illinois
$4.74M -$94.4K -4,675 -2%
Wells Fargo
20
Wells Fargo
California
$4.65M -$1.08M -53,273 -19%
CIP
21
Chartwell Investment Partners
Pennsylvania
$4.25M -$1.24M -61,301 -22%
Acadian Asset Management
22
Acadian Asset Management
Massachusetts
$4.13M +$1.28M +63,373 +44%
TAM
23
Tocqueville Asset Management
New York
$3.56M -$857K -42,440 -19%
Invesco
24
Invesco
Georgia
$3.31M -$69.2K -3,425 -2%
Russell Investments Group
25
Russell Investments Group
United Kingdom
$2.95M +$797K +39,456 +36%

PAHC Hedge Fund Activity: Q1 2022 in Review

153 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q1 2022, worth a combined $409M — down 1.9% from $417M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new PAHC positions and 15 closed out — a net gain of 8 holders — while 63 added to existing stakes and 46 trimmed.

The largest buyer was BlackRock, adding an estimated $4.11M. The largest seller was Fiduciary Management Inc, cutting an estimated $8.78M.

  • 153 institutional investors held Phibro Animal Health (PAHC) as of Q1 2022, up from 145 in Q4 2021.
  • Funds reported $409M of Phibro Animal Health stock for Q1 2022, down 1.9% quarter-over-quarter.
  • 23 funds opened new Phibro Animal Health positions in Q1 2022 and 15 closed out, a net change of +8 holders.
  • The largest Phibro Animal Health buyer in Q1 2022 was BlackRock, an estimated $4.11M added.
  • The largest Phibro Animal Health seller in Q1 2022 was Fiduciary Management Inc, an estimated $8.78M sold.

Based on aggregated 13F filings for Q1 2022.